-
Mashup Score: 8
Metabolic homeostasis is one of the most exquisitely tuned systems in mammalian physiology. Metabolic homeostasis requires multiple redundant systems to cooperate to maintain blood glucose concentrations in a narrow range, despite a multitude of physiological and pathophysiological pressures. Cancer is one of the canonical pathophysiological settings in which metabolism plays a key role. In this…
Source: bioRxivCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Advances in Cancer Immunotherapy: A Focus on Genitourinary Cancers | Wednesday, March 22 | Virtual - 1 year(s) ago
The 2023 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Bristol Myers Squibb, Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD) and Novartis Pharmaceuticals Corporation. (as of 3/8/2023) Michael Hurwitz, MDYale Cancer Center Tyler Stewart, MD UC San Diego Tian Zhang, MDUT Southwestern Medical…
Source: www.sitcancer.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Join me on March 22 for the @sitcancer #LearnACI live virtual Genitourinary Cancers program featuring in-depth education on all aspects of clinical implementation of genitourinary cancers. Register at: https://t.co/NIgGoxmILD @YaleCancer @SmilowCancer @OncoAlert
-
-
Mashup Score: 8Please wait whilst we redirect you - 1 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Happy to share this review written with the phenomenal surgeon-scientist Soki Kashima on the changing landscape of immunotherapy for RCC @YaleCancer @SmilowCancer @OncoAlert @kidneycan @IKCCorg @KidneyCancer https://t.co/f98HJ3EX3I
-
-
Mashup Score: 2Second-Line Therapy and Beyond in Clear Cell RCC - The ASCO Post - 2 year(s) ago
Transcript Disclaimer: This video transcript has not been proofread or edited and may contain errors. Dr. Vincent Xu: Welcome to The ASCO Post Roundtable series on Updates in Renal Cell Carcinoma. I’m Dr. Vincent Xu, medical oncologist at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute in Boston, and instructor of medicine at Harvard…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ASCOPost: Updates in Renal Cell Carcinoma, Part 2: Second-Line Therapy and Beyond in Clear Cell RCC https://t.co/DVOIXsVKV5 #kcsm #RCC…
-
-
Mashup Score: 1First-Line Therapy in Metastatic Clear Cell RCC - The ASCO Post - 2 year(s) ago
Transcript Disclaimer: This video transcript has not been proofread or edited and may contain errors. Dr. Vincent Xu: Hello. Welcome to The ASCO Post Roundtable Series on Updates in Renal Cell Carcinoma. I’m Dr. Vincent Xu. I’m a medical oncologist in the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute, and Instructor of Medicine at…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ASCOPost: Part 1: First-Line Therapy in Metastatic Clear Cell RCC https://t.co/pEGWKLNzlW #kcsm #RCC #kidneycancer #oncology @VincentWe…
-
-
Mashup Score: 0A fundraising page for David Braun - 2 year(s) ago
I’m excited to be participating in the 12th annual Closer to Free Ride on September 10th. I’ve signed up to support patient care and research at Smilow Cancer Hospital and Yale Cancer Center. 100% of the funds I raise goes directly to changing and saving lives. Will you support me with a donation today?
Source: Yale New Haven HospitalCategories: Latest Headlines, Oncologists1Tweet-
It is almost ride day! Please consider support my bike ride, with funds going to support cancer research and care: https://t.co/xC9W05rueT https://t.co/0o1CNkVWQI
-
-
Mashup Score: 3A fundraising page for David Braun - 2 year(s) ago
I’m excited to be participating in the 12th annual Closer to Free Ride on September 10th. I’ve signed up to support patient care and research at Smilow Cancer Hospital and Yale Cancer Center. 100% of the funds I raise goes directly to changing and saving lives. Will you support me with a donation today?
Source: Yale New Haven HospitalCategories: Hem/Oncs, Latest HeadlinesTweet-
On Sept. 10, I’ll be riding in the Closer to Free Ride to fundraise for cancer research and care @YaleCancer @SmilowCancer. I will be riding this year in Paris during @myESMO meeting. Please considering donating: https://t.co/xC9W05rueT Thank you!
-
-
Mashup Score: 2
A panel of kidney cancer experts discuss how therapeutic strategies in the neoadjuvant and adjuvant settings are affecting outcomes and how treatment selection in the first line has shifted approaches in the second and later lines of therapy.
Source: OncLiveCategories: Latest Headlines, Oncologists1Tweet-
RT @OncLive: Adjuvant and Neoadjuvant Treatments Chart New Course in Advanced RCC @BraunMDPhD @YaleCancer #kcsm https://t.co/u85aQFonly
-
-
Mashup Score: 1Progressive immune dysfunction with advancing disease stage in renal cell carcinoma - PubMed - 2 year(s) ago
The tumor immune microenvironment plays a critical role in cancer progression and response to immunotherapy in clear cell renal cell carcinoma (ccRCC), yet the composition and phenotypic states of immune cells in this tumor are incompletely characterized. We performed single-cell RNA and T cell rece …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Really excited to see this important work that provides critical experimental support to the exhausted CD8 T cell - TAM circuit we observe in ccRCC https://t.co/cnH1Fo0R3l. Amazing work from @KellyKersten8 @MaxKrummel and team! đź‘Ź https://t.co/JFtHlY3d9j
-
-
Mashup Score: 4Program Manager | Yale University - 2 year(s) ago
Job Details: A job opportunity at Yale University
Source: sjobs.brassring.comCategories: Hem/Oncs, Latest HeadlinesTweet-
The CMCO is looking for an energetic Program Manager and communicator to help us promote a collaborative research environment, a culture of diversity and inclusion, and our focus on mentoring, career development and innovative approaches to science. Apply: https://t.co/kuT1S5Om5g
-
The Center of Molecular and Cellular Oncology (CMCO) @YaleMed @YaleCancer is hiring a Program Manager! https://t.co/kuT1S5Om5g
-
RT @RachelPerryLab1: Delighted to share our lab’s new preprint, a 🧵(1/n): https://t.co/JNC5s98gn6